Exploring the antihyperglycemic potential of tetrapeptides devised from AdMc1 via different receptor proteins inhibition using in silico approaches.
Mustafa G, Mahrosh HS, Zafar M, Attique SA, Arif R.
Mustafa G, et al.
Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221103120. doi: 10.1177/03946320221103120.
Int J Immunopathol Pharmacol. 2022.
PMID: 35574607
Free PMC article.
Next, a ready-to-dock library of fifty tetrapeptides as potent inhibitors was prepared and docked against aldose reductase (AR), protein tyrosine phosphatase 1B (PTP1B), alpha-glucosidase, alpha-amylase and glycogen synthase kinase 3-beta as receptor proteins. Molecular dynamics …
Next, a ready-to-dock library of fifty tetrapeptides as potent inhibitors was prepared and docked against aldose reductase (AR), protein tyr …